EP Patent

EP0769936A1 — Self-emulsifying drug delivery system

Assigned to GD Searle LLC · Expires 1997-05-02 · 29y expired

What this patent protects

Oral pharmaceutical formulation which improves the bioavailability of pharmaceuticals which are substantially water and oil insoluble is disclosed. In addition to the pharmaceutical, the formulation includes an emulsifier, an oil and a solubilizer. Alternatively, the formulation …

USPTO Abstract

Oral pharmaceutical formulation which improves the bioavailability of pharmaceuticals which are substantially water and oil insoluble is disclosed. In addition to the pharmaceutical, the formulation includes an emulsifier, an oil and a solubilizer. Alternatively, the formulation includes an aqueous solution of solubilizer.

Drugs covered by this patent

Patent Metadata

Patent number
EP0769936A1
Jurisdiction
EP
Classification
Expires
1997-05-02
Drug substance claim
No
Drug product claim
No
Assignee
GD Searle LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.